Antibody cocktail against SARS-CoV-2 spike protein Grant US-11834493-B2 United States of America 05 Dec 2023
SARS-COV-2 PEPTIDES AND PROTEINS WITH REDUCED ADHERENCE TO ANGIOTENSIN CONVERTING ENZYME-2 Application WO-2023275060-A1 World Intellectual Property Organisation (WIPO) 05 Jan 2023
DETECTION AND MUTATIONAL ANALYSIS OF AN RNA VIRUS IN AN ENVIRONMENTAL SAMPLE Application WO-2022171313-A1 World Intellectual Property Organisation (WIPO) 18 Aug 2022
VARIANT STRAIN-BASED CORONAVIRUS VACCINES Application WO-2022155524-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
VARIANT STRAIN-BASED CORONAVIRUS VACCINES Application WO-2022155530-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
STABLE CORONAVIRUS PROTEINS AND VACCINE COMPOSITIONS THEREOF Application WO-2022146484-A1 World Intellectual Property Organisation (WIPO) 07 Jul 2022
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2… Grant US-11345741-B2 United States of America 31 May 2022
ANTIBODIES AGAINST SARS-COV-2 Application WO-2022067269-A2 World Intellectual Property Organisation (WIPO) 31 Mar 2022
ANTIBODY AGAINST CORONAVIRUS Application WO-2022059801-A1 World Intellectual Property Organisation (WIPO) 24 Mar 2022
CORONAVIRUS-DERIVED RECEPTOR BINDING DOMAIN VARIANT WITH REDUCED ACE2 BINDING CAPACITY… Application WO-2022050521-A1 World Intellectual Property Organisation (WIPO) 10 Mar 2022
REAGENTS AND METHODS FOR PREVENTING, TREATING OR LIMITING SEVERE ACUTE RESPIRATORY… Application WO-2022046583-A1 World Intellectual Property Organisation (WIPO) 03 Mar 2022
CONSTRUCTION AND APPLICATION OF FUSION PROTEIN VACCINE PLATFORM Application WO-2022002180-A1 World Intellectual Property Organisation (WIPO) 06 Jan 2022
ANTIGEN-BINDING PROTEIN TO SARS-CoV-2 Application WO-2021206636-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2… Application WO-2021195418-A1 World Intellectual Property Organisation (WIPO) 30 Sep 2021